Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 0 | 0 | 0 | 7,500 | 0 |
Gross Profit | N/A | N/A | N/A | 7,500 | N/A |
Operating Expenses | 34,419 | 38,522 | 44,538 | 36,143 | 36,380 |
Operating Income | -34,419 | -38,522 | -44,538 | -28,643 | -36,380 |
Other Income | 10 | 160 | 205 | 207 | -138 |
Pre-tax Income | -34,409 | -38,362 | -44,333 | -28,436 | -36,518 |
Net Income Continuous | -34,409 | -38,362 | -44,333 | -28,436 | -37,632 |
Net Income | $-34,409 | $-38,362 | $-44,333 | $-28,436 | $-37,632 |
EPS Basic Total Ops | -3.50 | -3.90 | -4.50 | -2.90 | -4.00 |
EPS Basic Continuous Ops | -3.50 | -3.91 | -4.52 | -2.91 | -3.93 |
EPS Diluted Total Ops | -3.50 | -3.90 | -4.50 | -2.90 | -4.00 |
EPS Diluted Continuous Ops | -3.50 | -3.91 | -4.52 | -2.91 | -3.93 |
EBITDA(a) | $-29,881 | $-36,685 | $-42,800 | $-26,622 | $-34,009 |